Oculus Innovative Sciences Sells Latin America Business to Invekra S.A.P.I. de C.V. for $19.5 Million in Cash Oct 31, 2016
Oculus Innovative Sciences Announces Fiscal Second Quarter 2017 Financial Results and Conference Call Oct 27, 2016
Oculus Innovative Sciences Launches Lasercyn™ into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels Aug 30, 2016
Oculus Innovative Sciences Receives U.S. FDA Approval for New Post-Dermal-Procedures Product for Removal of Foreign Material Including Microorganisms Aug 24, 2016
Oculus Innovative Sciences Receives Australian Approvals to Market Sterile Microcyn®-Based Antimicrobial Solutions and Hydrogel Dressings Aug 11, 2016
Oculus Innovative Sciences Reports Financial Results for First Quarter of Fiscal Year 2017 Jul 28, 2016
Oculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call Jul 19, 2016
Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016 Jun 16, 2016
